STOCKS TELEGRAPH

Tag: CLRB

  • Early Morning Vibes: Top 4 Stocks Trending on Wednesday

    On December 29, the American stock indices closed in the red. The S&P 500 at the beginning of the session renewed its all-time high, but by its close it dropped 0.22% to 3727 points, the Dow Jones also lost 0.22%, the NASDAQ fell 0.38%. The news background remained calm, but investors preferred to fix some of their positions. The healthcare sector took the lead in growth with a result of + 0.44%, while the real estate sector corrected by 0.71%.

    Company news

    Fulgent Genetics (FLGT: + 8.7%) will provide COVID-19 diagnostic tests to New York City students and educational workers.

    Activist investor Third Point sent a letter to Intel management (INTC: + 4.9%) urging them to consider changes to the company’s strategy.

    Arcturus Therapeutics (ARCT: -54.2%) has published the results of the first phase of clinical trials of a COVID-19 vaccine, which turned out to be weak.

    Today, world stock exchanges are showing mostly positive dynamics. Investors are focusing on the prospects for increasing the volume of direct payments to Americans. Senate Majority Leader Mitch McConnell has blocked an attempt to vote on raising the benefit from $ 600 to $ 2,000, so the timing of the discussion remains uncertain. A number of Republicans do not support the president’s initiative to increase the lump sum, pointing to the problem of the budget deficit and high public debt, which hinders the increase in government spending. In the meantime, Americans will start receiving checks for $ 600 today as part of the previously approved economic stimulus program.
     

    On the front of the fight against COVID-19 in the United States, there is no significant positive so far. Colorado has recorded the first patient with a British modification of the coronavirus. The increase in incidence has slowed slightly, but a new outbreak is forecast after the holidays. The number of hospitalized in the United States already exceeds 124 thousand, and the trend remains negative. The vaccination campaign is very slow: so far only 2.13 million have been vaccinated. As Joseph Biden noted, if the process is not accelerated, it may take years, not months, to complete vaccination. This is a significant risk for stocks, but for now investors tend to believe that the acquisition of mass immunity can be accelerated.

    Today Top Movers

    AstraZeneca PLC ADR (AZN), a Drug Manufacturers company, soared about 2.38% ‎at $51.09 in pre-market trading today following its Covid-19 vaccine approval in the U.K.

    Guardion Health Sciences Inc (GHSI) share price jumped 7.029% to $0.41 during early morning ‎trading session on Wednesday following the declaration of appointment of Bret Scholtes, as its President and Chief Executive Officer.

    NXT-ID Inc (NXTD) stock ascended 9.16% at $1.43 in the pre-‎market trading today. 

    American Battery Metals Corp USD (ABML) gained over 1.43% at $1.42 in pre-market ‎trading on Wednesday.‎

    Top Upgrades & Downgrades

    AlphaValue turned bullish on AstraZeneca PLC ADR (AZN)‎, upgrading the ‎stock to “Add”.

    ‎Baird turned bullish on Caterpillar Inc. (NYSE: CAT), reiterating the stock at ‎‎“Outperform” but lifting the target from $206 to $220, representing potential ‎upside of 24.54% from Tuesday’s close.

    Daiwa turned bullish on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)‎ , initiating the stock at ‎‎“Outperform” and assigning the target to $250, representing potential upside ‎of 7.07% from Tuesday’s close.

    Latest Insider Activity

    Lemonade Inc. (LMND) Chief Insurance Officer Peters John Sheldon announced the sale of shares taking place on Dec 28 at $118.49 for some 5,000 shares. The total came to more than $0.59 million.

    Pinterest Inc. (PINS) Chairman, President, CEO, Co-F Silbermann Benjamin sold on Dec 24 a total 105,000 shares at $71.55 on average. The insider’s sale generated proceeds of almost $7.51 million.

    Cellectar Biosciences Inc. (CLRB) Chief Business Officer Longcor Jarrod declared the purchase of shares taking place on Dec 28 at $1.35 for some 29,630 shares. The transaction amount was around $40001.

    TRACON Pharmaceuticals Inc. (TCON) 10% Owner Opaleye Management Inc. bought on Dec 22 a total 2,293,371 shares at $8.06 on average. The purchase cost the insider an estimated $4.0 million.

  • Don’t Miss these 15 Biotechnology Value Stocks

    Biotech and Major Pharmaceuticals are back in the news with the Covid-19 Pandemic. Life science investors basically endorse developments that might decide the human race’s future, but what would invest in ‘cures’ mean from a cash flow point of view?
    On Thursday, a panel of independent health professionals voted 17-4 in support of the Food and Drug Administration(FDA), providing emergency permission to the applicant for the COVID-19 vaccine from BioNTech and Pfizer Inc.
    In other news Gilead Sciences Inc (GILD) revealed that it would buy MYR GmbH in cash for roughly EUR 1.15 billion ($1.39 billion), granting it access to the German biotech company’s therapy for extreme viral hepatitis.
    In yesterday’s trading session, the following stocks were the major key players.

    Immutep Limited (NASDAQ:IMMP) shares were trading up 163.43% at $5.69 at the time of writing on Thursday after declaring that its Chinese partner, EOC Pharma will commence a new Phase II clinical trial in up to 152 metastatic breast cancer patients in China.

    Immutep Limited (NASDAQ:IMMP) share price went from a low point around $0.53 to briefly over $3.10 in past 52 weeks, though shares have since pulled back to $5.69. IMMP market cap has remained high, hitting $280.46M at the time of writing.

    If we look at the recent analyst rating IMMP, B. Riley FBR initiated coverage on IMMP shares with a Buy rating.

    TG Therapeutics Inc. (TGTX) stock soar by 40.85% to $41.72 after reportingpositive topline results from the ULTIMATE I & II Phase 3 studies evaluating Ublituximab Monotherapy for the treatment of patients with multiple sclerosis. The most recent rating by JP Morgan, on September 01, 2020, is at an Overweight.

    Heat Biologics Inc. (HTBX) last closed at $0.93, in a 52-week range of $0.19 to $4.30.

    Sangamo Therapeutics Inc. (NASDAQ:SGMO) Shares headed rising, higher as much as 52.98%. Pfizer Inc. (PFE) and Sangamo Therapeutics, Inc. (SGMO), on December 7, 2020 declared updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec (SB-525 or PF-07055480), an investigational gene therapy for patients with severe hemophilia A. The most recent rating by BofA Securities, on September 08, 2020, is at a Buy.

    Entera Bio Ltd. (NASDAQ:ENTX) rose 8.18% after gaining more than $0.09 on Thursday following the firm revealed FDA approval of IND application for EB613 – an Oral Human Parathyroid Hormone (1-34) for the treatment of Osteoporosis.

    Aytu BioScience Inc. (AYTU) last closed at $8.13, in a 52-week range of $3.35 to $29.90 after announcing definitive merger agreement with Neos Therapeutics, creating a combined $100M revenuespecialty pharmaceutical company.

    Amarin Corporation plc (AMRN) stock soar by 8.04% to $4.97. The most recent rating by JP Morgan, on September 29, 2020, is at a Neutral.

    Editas Medicine Inc. (NASDAQ:EDIT) Shares headed rising, higher as much as 32.15% following an announcement from the company that it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1/2 clinical trial of EDIT-301. The most recent rating by Wells Fargo, on December 10, 2020, is at an Overweight.

    Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) rose 9.04% after gaining more than $0.15 on Thursday.

    Akebia Therapeutics Inc. (AKBA) last closed at $2.95, in a 52-week range of $2.09 to $13.71. The firm recently revealed the latest scheduled program of AkebiaShares, a peer-to-peer educational series for the kidney community.

    BioCryst Pharmaceuticals Inc. (BCRX) stock soar by 5.37% to $7.65. The company recently announced transactions with Royalty Pharma (RPRX) and Athyrium Capital Management, LP, totaling $325 million in funding for BioCryst, with $250 million available at closing, to support the launch of ORLADEYO™ (berotralstat) in hereditary angioedema (HAE) and the development of its oral Factor D inhibitor, BCX9930. The most recent rating by JP Morgan, on September 29, 2020, is at an Overweight.

    Acasti Pharma Inc. (NASDAQ:ACST) Shares headed rising, higher as much as 1.70%. The company on November 16, 2020 released its operating and financial results for the second quarter of fiscal 2021 ended September 30, 2020. The most recent rating by Oppenheimer, on September 01, 2020, is at a Perform.

    Ocugen Inc. (NASDAQ:OCGN) fall -1.79% after losing more than -$0.01 on Thursday after reporting that it will postpone its 2020 Annual Meeting of Stockholders to December 23, 2020.

    Inovio Pharmaceuticals Inc. (INO) last closed at $11.36, in a 52-week range of $2.42 to $33.79. The firm recently revealedthe successful dosing of its first subject in its Phase 2 clinical trial for COVID-19 DNA vaccine candidate, INO-4800, in China. Analysts have a consensus price target of $13.71.

    Cellectar Biosciences Inc. (CLRB) stock soar by 3.47% to $2.09. The most recent rating by Oppenheimer, on July 01, 2020, is at an Outperform.

  • Market Movers: What changed for these 28 stocks while you were sleeping

    Market Movers: What changed for these 28 stocks while you were sleeping

    Aurora Cannabis Inc. (NYSE: ACB) shares are trading down -15.66% at $7.0 at the time of writing. The company’s 52-week range was noted as $3.71 to $45.48. Meanwhile, Aurora Cannabis revealed Proposed Public Offering.

    Pareteum Corporation (TEUM) tumbled over -57.47% at $0.1999 in pre-market trading today after Pareteum Delivered Business Update in Open Letter to Shareholders.

    Waitr Holdings Inc. (WTRH), a Software – Application company, rose about 6.59% at $2.75 in pre-market trading Wednesday.

    Jumia Technologies AG (JMIA) stock moved up 4.49 percent to $13.49 in the pre-market trading after Jumia posted Third Quarter 2020 Results.

    Tilray Inc. (TLRY) lost over -5.76% at $7.85 in pre-market trading Wednesday 11 November 2020 after the pot company vows profit despite slow sales growth.

    9F Inc. (JFU) is up more than 6.73% at $1.11 in pre-market hours Wednesday 11 November 2020 after the company shares had dropped over -14.75% to $1.04 in the last trading session.

    InnSuites Hospitality Trust (IHT) stock plunged -6.86% to $1.9 in the pre-market trading.

    Before the trading started on 11 November 2020, Destination XL Group Inc. (DXLG) is up 6.32% to reach $0.3296 after the largest omni-channel specialty retailer of big & tall men’s apparel, revealed on November 06, 2020, to announce its third-quarter 2020 results before the market opens on Friday, November 20, 2020. The stock has been trading in a 52-week range of $0.22 to $1.56.

    Novavax Inc. (NVAX) stock soared 5.28% to $82.9 in the pre-market trading following the news that Novavax, working with Morrisville firm, secured fast-track status for Covid-19 vaccine candidate. The most recent rating by H.C. Wainwright, on August 06, 2020, is at a Buy.

    Carnival Corporation & plc (NYSE: CUK) shares are trading up 6.02% at $15.67 at the time of writing after the company announced the sale of 67.1 million shares of Carnival Corporation common stock under its previous $1 billion “on the market” stock offering plan. The company’s 52-week range was noted as $7.08 to $49.03.

    Ballard Power Systems Inc. (BLDP) grew over 4.91% at $15.81 in pre-market trading today after its latest performance.

    Farfetch Limited (FTCH), an Internet Retail company, rose about 4.54% at $42.86 in pre-market trading Wednesday following the announcement on November 5, 2020, that Alibaba and Richemont will be investing $600 million in private convertible notes issued by Farfetch Limited.

    FSD Pharma Inc. (HUGE) stock moved up 14.39 percent to $1.59 in the pre-market trading as Raza Bokhari, CEO of FSD Pharma Inc (NASDAQ: HUGE), revealed that the biopharma company is fully funded to continue progress in its Phase 2 trial on the treatment of patients with hospitalized coronavirus.

    Fuel Tech Inc. (FTEK) gained over 64.26% at $1.25 in pre-market trading Wednesday 11 November 2020 after Fuel Tech Reported 2020 Third Quarter Financial Results.

    HEXO Corp. (HEXO) is down more than -3.88% at $0.75 in pre-market hours Wednesday 11 November 2020 following the announcement by the company that Health Canada has granted Trent MacDonald’s security clearance request under the Cannabis Act. The stock had dropped over -5.99% to $0.78 in the last trading session.

    Before the trading started on 11 November 2020, Phoenix Tree Holdings Limited (DNK) is up 4.61% to reach $1.59. It has been trading in a 52-week range of $1.27 to $13.90.

    DouYu International Holdings Limited (DOYU) stock soared 4.7% to $14.25 in the pre-market trading as China’s leading game-centric live streaming site and a leader in the value chain for eSports, today revealed its financial results for the third quarter. The most recent rating by China Renaissance, on November 05, 2020, is at a Hold.

    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading down -13.38% at $0.3794 at the time of writing following the report that Sundial Growers Inc. (NASDAQ: SNDL) Shares Could Be 47% Below Their Intrinsic Value Estimate. The company’s 52-week range was noted as $0.14 to $4.02.

    Lyft Inc. (LYFT) grew over 5.69% at $38.1 in pre-market trading today following the news that it was working on a new service to take a slice of the burgeoning food-delivery market as it works to make up for a 48% drop in quarterly revenue and a slow recovery of ride-hail demand.

     

    Li Auto Inc. (LI), an Auto Manufacturers company, dropped about -3.21% at $24.43 in pre-market trading Wednesday after the company today announced a voluntary recall on some of its Li ONEs.

     

    Gulfport Energy Corporation (GPOR) stock moved up 6.75 percent to $0.28 in the pre-market trading.

     

    Ayro Inc. (AYRO) is down more than -4.98% at $2.67 in pre-market hours Wednesday 11 November 2020. The stock had dropped over -3.77% to $2.81 in the last trading session.  An engineer and manufacturer of light-duty, urban, and short-haul electric vehicles (EVs), on November 6, 2020, announced financial results for its third quarter of 2020.

     

    Before the trading started on 11 November 2020, Cellectar Biosciences Inc. (CLRB) is up 7.14% to reach $1.2 after, Maxim Group analyst Jason McCarthy assigned a buy rating to Cellectar Biosciences (CLRB) and set a $3.00 price target. It has been trading in a 52-week range of $1.01 to $3.33.

     

    GameStop Corp. (GME) stock soared 5.41% to $11.7 in pre-market trading. The most recent rating by Jefferies, on October 12, 2020, is at a Hold. The company announced that it will redeem $125 million in principal amount of its 6.75% Senior Notes due 2021 on December 11, 2020. This voluntary early redemption covers approximately 63% of the outstanding Notes.

     

    Weidai Ltd. (NYSE: WEI) shares are trading down -3.47% at $1.39 at the time of writing. The company’s 52-week range was noted as $0.73 to $6.40.

     

    Performant Financial Corporation (PFMT) grew over 10.16% at $1.03 in pre-market trading today after a leading provider of technology-enabled recovery and related analytics services in the United States, today reported financial results for its third quarter ended September 30, 2020.

     

    Five Prime Therapeutics Inc. (FPRX), a biotechnology company, rose about 278.46% at $20.21 in pre-market trading Wednesday after the company had announced that its gastric cancer drug met all three of its Phase 2 study efficacy endpoints.

     

    Datadog Inc. (DDOG) stock moved down -9.3 percent to $83.99 in the pre-market trading following an estimate-beating sales outlook, but investors who have seen the stock more than double this year have not been pleased. Furthermore, Datadog Released Monitoring Features for Detecting and Debugging DNS Issues.